163 related articles for article (PubMed ID: 24945990)
1. Survivin delta Ex3 overexpression in thyroid malignancies.
Waligórska-Stachura J; Andrusiewicz M; Sawicka-Gutaj N; Biczysko M; Jankowska A; Kubiczak M; Czarnywojtek A; Wrotkowska E; Ruchała M
PLoS One; 2014; 9(6):e100534. PubMed ID: 24945990
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression.
Sawicka-Gutaj N; Waligórska-Stachura J; Andrusiewicz M; Biczysko M; Sowiński J; Skrobisz J; Ruchała M
Tumour Biol; 2015 Sep; 36(10):7859-63. PubMed ID: 25946974
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of survivin splice variants in pituitary tumors.
Waligórska-Stachura J; Andrusiewicz M; Sawicka-Gutaj N; Kubiczak M; Jankowska A; Liebert W; Czarnywojtek A; Waśko R; Blanco-Gangoo AR; Ruchała M
Pituitary; 2015 Jun; 18(3):410-6. PubMed ID: 25107550
[TBL] [Abstract][Full Text] [Related]
4. Targeting of the anti-apoptotic gene survivin in human thyroid carcinoma.
Chen Z; Liu N; Zhu G; Dralle H; Hoang-Vu C
Int J Mol Med; 2012 Sep; 30(3):465-72. PubMed ID: 22751750
[TBL] [Abstract][Full Text] [Related]
5. Detection of survivin 2α gene expression in thyroid nodules.
Kyani K; Babaei E; Feizi MA; Vandghanooni S; Montazeri V; Halimi M
J Cancer Res Ther; 2014; 10(2):312-6. PubMed ID: 25022384
[TBL] [Abstract][Full Text] [Related]
6. Survivin-deltaEx3: a novel biomarker for diagnosis of papillary thyroid carcinoma.
Vandghanooni S; Eskandani M; Montazeri V; Halimi M; Babaei E; Feizi MA
J Cancer Res Ther; 2011; 7(3):325-30. PubMed ID: 22044815
[TBL] [Abstract][Full Text] [Related]
7. BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Moore AS; Alonzo TA; Gerbing RB; Lange BJ; Heerema NA; Franklin J; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S
Pediatr Blood Cancer; 2014 Apr; 61(4):647-52. PubMed ID: 24127439
[TBL] [Abstract][Full Text] [Related]
8. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas.
Mahotka C; Krieg T; Krieg A; Wenzel M; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD
Int J Cancer; 2002 Jul; 100(1):30-6. PubMed ID: 12115583
[TBL] [Abstract][Full Text] [Related]
9. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
He XF; Wen DG; Hou JQ; He J; Cen JN
Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
[TBL] [Abstract][Full Text] [Related]
10. Early diagnostic value of survivin and its alternative splice variants in breast cancer.
Khan S; Bennit HF; Turay D; Perez M; Mirshahidi S; Yuan Y; Wall NR
BMC Cancer; 2014 Mar; 14():176. PubMed ID: 24620748
[TBL] [Abstract][Full Text] [Related]
11. The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers.
Pannone G; Santoro A; Pasquali D; Zamparese R; Mattoni M; Russo G; Landriscina M; Piscazzi A; Toti P; Cignarelli M; Lo Muzio L; Bufo P
Thyroid; 2014 Mar; 24(3):511-9. PubMed ID: 24117205
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional expression analysis of survivin splice variants reveals differential expression of survivin-3α in breast cancer.
Moniri Javadhesari S; Gharechahi J; Hosseinpour Feizi MA; Montazeri V; Halimi M
Genet Test Mol Biomarkers; 2013 Apr; 17(4):314-20. PubMed ID: 23368531
[TBL] [Abstract][Full Text] [Related]
13. Changes in the expression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clinical significance.
Selemetjev SA; Savin SB; Paunovic IR; Tatic SB; Cvejic D
Wien Klin Wochenschr; 2015 May; 127(9-10):337-44. PubMed ID: 25471003
[TBL] [Abstract][Full Text] [Related]
14. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional expression of survivin and its splice variants in endometriosis.
Fujino K; Ueda M; Takehara M; Futakuchi H; Kanda K; Yamashita Y; Terai Y; Ueki M
Mol Hum Reprod; 2006 Jun; 12(6):383-8. PubMed ID: 16644787
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of survivin splice variants in diffusely infiltrating astrocytoma.
Huang Y; Chen X; Chen N; Nie L; Xu M; Zhou Q
J Clin Pathol; 2011 Nov; 64(11):953-9. PubMed ID: 21730264
[TBL] [Abstract][Full Text] [Related]
17. High expression of survivin and its splice variants survivin ΔEx3 and survivin 2 B in oral cancers.
Mishra R; Palve V; Kannan S; Pawar S; Teni T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Oct; 120(4):497-507. PubMed ID: 26346910
[TBL] [Abstract][Full Text] [Related]
18. Survivin isoform Delta Ex3 regulates tumor spheroid formation.
Espinosa M; Ceballos-Cancino G; Callaghan R; Maldonado V; Patiño N; Ruíz V; Meléndez-Zajgla J
Cancer Lett; 2012 May; 318(1):61-7. PubMed ID: 22155745
[TBL] [Abstract][Full Text] [Related]
19. Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.
Batista FA; Ward LS; Marcello MA; Martins MB; Peres KC; Torricelli C; Bufalo NE; Soares FA; da Silva MJ; Assumpção LV
J Endocrinol Invest; 2016 Apr; 39(4):423-9. PubMed ID: 26370671
[TBL] [Abstract][Full Text] [Related]
20. The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival.
Antonacopoulou AG; Floratou K; Bravou V; Kottorou A; Dimitrakopoulos FI; Marousi S; Stavropoulos M; Koutras AK; Scopa CD; Kalofonos HP
Cell Oncol (Dordr); 2011 Aug; 34(4):381-91. PubMed ID: 21538024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
